Vitasora Health Ltd (VHL) - Financial and Strategic SWOT Analysis Review
Description
Vitasora Health Ltd (VHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Vitasora Health Ltd (Vitasora Health), formerly Respiri Ltd, is a digital health software provider that has expanded its focus from respiratory health to broader chronic care management. The company develops medical devices and mobile health applications aimed at improving health outcomes for patients with chronic conditions, particularly respiratory disorders. Its main product, wheezo, is an FDA-approved device that detects wheeze and integrates with Remote Patient Monitoring programs. Vitasora Health's services are utilized by healthcare providers to enhance patient outcomes and reduce medical costs. The company collaborates with healthcare organizations, payers, and Accountable Care Organizations (ACOs) to deliver scalable, tailored solutions. Vitasora Health operates through distribution partners to reach its target markets, including the US market. The company focuses on providing seamless care management through multi-device integration and virtual clinical support. Vitasora Health is headquartered in Melbourne, Victoria, Australia.
Vitasora Health Ltd Key Recent Developments
Oct 24,2025: Vitasora Health Expands Evolent Care Partnership to Drive US Growth Strategy
Oct 02,2025: Vitasora Locks In High-Growth Home Care Partnership with Iris Medical Group Covering 12,000+ Patients
Aug 13,2025: Vitasora Health Announces Expansion of Existing Agreement With Tampa Family Health Centers
Jun 30,2025: Vitasora Announces Expansion of TPAC Contract
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Vitasora Health Ltd (Vitasora Health), formerly Respiri Ltd, is a digital health software provider that has expanded its focus from respiratory health to broader chronic care management. The company develops medical devices and mobile health applications aimed at improving health outcomes for patients with chronic conditions, particularly respiratory disorders. Its main product, wheezo, is an FDA-approved device that detects wheeze and integrates with Remote Patient Monitoring programs. Vitasora Health's services are utilized by healthcare providers to enhance patient outcomes and reduce medical costs. The company collaborates with healthcare organizations, payers, and Accountable Care Organizations (ACOs) to deliver scalable, tailored solutions. Vitasora Health operates through distribution partners to reach its target markets, including the US market. The company focuses on providing seamless care management through multi-device integration and virtual clinical support. Vitasora Health is headquartered in Melbourne, Victoria, Australia.
Vitasora Health Ltd Key Recent Developments
Oct 24,2025: Vitasora Health Expands Evolent Care Partnership to Drive US Growth Strategy
Oct 02,2025: Vitasora Locks In High-Growth Home Care Partnership with Iris Medical Group Covering 12,000+ Patients
Aug 13,2025: Vitasora Health Announces Expansion of Existing Agreement With Tampa Family Health Centers
Jun 30,2025: Vitasora Announces Expansion of TPAC Contract
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
45 Pages
- Section 1 - About the Company
- Vitasora Health Ltd - Key Facts
- Vitasora Health Ltd - Key Employees
- Vitasora Health Ltd - Key Employee Biographies
- Vitasora Health Ltd - Major Products and Services
- Vitasora Health Ltd - History
- Vitasora Health Ltd - Company Statement
- Vitasora Health Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Vitasora Health Ltd - Business Description
- Geographical Segment: Australia
- Performance
- Geographical Segment: USA
- Performance
- R&D Overview
- Vitasora Health Ltd - Corporate Strategy
- Vitasora Health Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Vitasora Health Ltd - Strengths
- Vitasora Health Ltd - Weaknesses
- Vitasora Health Ltd - Opportunities
- Vitasora Health Ltd - Threats
- Vitasora Health Ltd - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Vitasora Health Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Vitasora Health Ltd, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Vitasora Health Ltd, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 24, 2025: Vitasora Health Expands Evolent Care Partnership to Drive US Growth Strategy
- Oct 02, 2025: Vitasora Locks In High-Growth Home Care Partnership with Iris Medical Group Covering 12,000+ Patients
- Aug 13, 2025: Vitasora Health Announces Expansion of Existing Agreement With Tampa Family Health Centers
- Jun 30, 2025: Vitasora Announces Expansion of TPAC Contract
- Apr 09, 2025: Supply Chain Resilience and U.S. Policy Momentum Supports Respiri Remote Patient Monitoring Growth Strategy
- Feb 24, 2025: Dr Tom Takubo to Retire, Jonathan Adams Appointed to Respiri Board
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Vitasora Health Ltd, Key Facts
- Vitasora Health Ltd, Key Employees
- Vitasora Health Ltd, Key Employee Biographies
- Vitasora Health Ltd, Major Products and Services
- Vitasora Health Ltd, History
- Vitasora Health Ltd, Subsidiaries
- Vitasora Health Ltd, Key Competitors
- Vitasora Health Ltd, Ratios based on current share price
- Vitasora Health Ltd, Annual Ratios
- Vitasora Health Ltd, Annual Ratios (Cont...1)
- Vitasora Health Ltd, Annual Ratios (Cont...2)
- Vitasora Health Ltd, Interim Ratios
- Vitasora Health Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Vitasora Health Ltd, Medical Equipment, Deals By Type, 2020 to YTD 2026
- Vitasora Health Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Vitasora Health Ltd, Performance Chart (2021 - 2025)
- Vitasora Health Ltd, Ratio Charts
- Vitasora Health Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
- Vitasora Health Ltd, Medical Equipment, Deals by Type, 2020 to YTD 2026
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
